MARKET

TENX

TENX

Tenax Therapeut
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.580
-0.030
-1.86%
After Hours: 1.700 +0.12 +7.59% 18:24 09/18 EDT
OPEN
1.630
PREV CLOSE
1.610
HIGH
1.659
LOW
1.580
VOLUME
134.84K
TURNOVER
--
52 WEEK HIGH
2.680
52 WEEK LOW
0.2500
MARKET CAP
19.94M
P/E (TTM)
-1.1668
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile

Analyst Price Target

The average TENX stock price target is 4.225 with a high estimate of 4.450 and a low estimate of 4.000.

Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About TENX
Tenax Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing products for the critical care market. The Company's main product is levosimendan. Levosimendan is a calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure. Levosimendan represents therapeutic modalities for the treatment of Low Cardiac Output Syndrome (LCOS), septic shock and other critical care conditions. The therapeutic effects of levosimendan are mediated through increased cardiac contractility by calcium sensitization of troponin C, resulting in a positive inotropic effect, which is not associated with substantial increases in oxygen demand; opening of potassium channels in the vasculature smooth muscle, resulting in a vasodilatory effect on all vascular beds, and opening of mitochondrial potassium channels in cardiomyocytes, resulting in a cardioprotective effect.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Tenax Therapeutics Inc stock information, including NASDAQ:TENX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TENX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TENX stock methods without spending real money on the virtual paper trading platform.